Archives

by in
Entry Author Date Location
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say 08/26/09 Seattle
FDA OKs Risperdal Consta for Bipolar 05/18/09 Boston
Alkermes Knocks on Door of Biotech Big Leagues, Aims to Make Drugs of its Own 02/12/09 Boston
TheraGenetics Bought by Avacta 01/29/09 Boston
Omeros Grabs $3.1M 01/28/09 Seattle
Fidelity Biosciences Pumps $65M into EnVivo Pharma 10/31/08 Boston
Page 2 of 2 « previous page